ATR
AptarGroup, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -5.6% ·
share flow +2.3% ·
net new positions -5.9%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 120 | -2 | 42.63M | $5.34B | +4 | −7 |
| Q1 2026 | 126 | -2 | 40.91M | $5.15B | +4 | −7 |
| Q4 2025 | 127 | -1 | 43.99M | $5.36B | +2 | −2 |
| Q3 2025 | 21 | +2 | 26.07M | $3.48B | +3 | −2 |
| Q2 2025 | 17 | -1 | 21.99M | $3.45B | — | −1 |
| Q1 2025 | 15 | +2 | 6.12M | $916.34M | +2 | — |
| Q4 2024 | 13 | 0 | 5.71M | $901.59M | — | — |
| Q3 2024 | 12 | 0 | 3.13M | $504.15M | — | — |
| Q2 2024 | 12 | — | 3.26M | $461.78M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 7.08M | — | $1.11B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 6.24M | — | $976.08M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 3 | State Street Global Advisors ✦ (passive) | 2.87M | +1.5% | $448.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 2.06M | — | $322.00M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 5 | Geode Capital Management ✦ (passive) | 1.75M | +3.7% | $282.87M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passive) | 755.49K | -1.9% | $118.18M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Millennium Management ✦ | 475.39K | +93.1% | $74.37M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 405.07K | +136.0% | $62.77M | 0.1% | ▲ Add | 5 | SEC ↗ ×5 |
| 9 | Renaissance Technologies ✦ | 93.10K | -24.9% | $14.56M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 70.88K | +25.3% | $11.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 63.21K | +4.3% | $9.89M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 12 | T. Rowe Price ✦ | 46.57K | +3.0% | $7.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 31.36K | -1.2% | $4.91M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Wellington Management ✦ | 14.93K | -0.7% | $2.34M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 14.31K | -69.1% | $2.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 11.59K | +83.5% | $1.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 10.43K | -69.7% | $1.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $549,006 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 538 holders, 58.90M shares, $7.20B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 765 sh · $99,733
Officer · 3.42K sh · $456,546
Officer · 325 sh · $43,730
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology